|
1
|
Sun X, Song Y, Tai X, Liu B and Ji W:
MicroRNA expression and its detection in human supraglottic
laryngeal squamous cell carcinoma. Biomed Rep. 1:743–746.
2013.PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Luo J, Wu J, Li Z, Qin H, Wang B, Wong TS,
Yang W, Fu QL and Lei W: miR-375 suppresses IGF1R expression and
contributes to inhibition of cell progression in laryngeal squamous
cell carcinoma. Biomed Res Int. 2014:3745982014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo Y, Fu W, Chen H, Shang C and Zhong M:
miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma
cells partly through down-regulation of the S100A8 protein. Oncol
Rep. 27:1097–1103. 2012.PubMed/NCBI
|
|
6
|
Cosetti M, Yu GP and Schantz SP: Five-year
survival rates and time trends of laryngeal cancer in the US
population. Arch Otolaryngol Head Neck Surg. 134:370–379. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang W, Lin P, Han C, Cai W, Zhao X and
Sun B: Vasculogenic mimicry contributes to lymph node metastasis of
laryngeal squamous cell carcinoma. J Exp Clin Cancer Res.
29:602010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ying SY, Chang DC, Miller JD and Lin SL:
The microRNA: Overview of the RNA gene that modulates gene
functions. Methods Mol Biol. 342:1–18. 2006.PubMed/NCBI
|
|
10
|
Maroney PA, Yu Y and Nilsen TW: MicroRNAs,
mRNAs, and translation. Cold Spring Harb Symp Quant Biol.
71:531–535. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao Y and Srivastava D: A developmental
view of microRNA function. Trends Biochem Sci. 32:189–197. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tahara H, Kay MA, Yasui W and Tahara E:
MicroRNAs in cancer: The 22nd Hiroshima cancer Seminar/the 4th
Japanese Association for RNA Interference Joint International
Symposium, 30 August 2012, Grand Prince Hotel Hiroshima. Jpn J Clin
Oncol. 43:579–582. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Karatas OF, Yuceturk B, Suer I, Yilmaz M,
Cansiz H, Solak M, Ittmann M and Ozen M: Role of miR-145 in human
laryngeal squamous cell carcinoma. Head Neck. 38:260–266. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tian L, Zhang J, Ge J, Xiao H, Lu J, Fu S,
Liu M and Sun Y: MicroRNA-205 suppresses proliferation and promotes
apoptosis in laryngeal squamous cell carcinoma. Med Oncol.
31:7852014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tian Y, Fu S, Qiu GB, Xu ZM, Liu N, Zhang
XW, Chen S, Wang Y, Sun KL and Fu WN: MicroRNA-27a promotes
proliferation and suppresses apoptosis by targeting PLK2 in
laryngeal carcinoma. BMC Cancer. 14:6782014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu D, Zhou Y, Pan H, Zhou J, Fan Y and Qu
P: microRNA-99a inhibiting cell proliferation, migration and
invasion by targeting fibroblast growth factor receptor 3 in
bladder cancer. Oncol Lett. 7:1219–1224. 2014.PubMed/NCBI
|
|
18
|
Huang L, Luo J, Cai Q, Pan Q, Zeng H, Guo
Z, Dong W, Huang J and Lin T: MicroRNA-125b suppresses the
development of bladder cancer by targeting E2F3. Int J Cancer.
128:1758–1769. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang L, Wong CM, Ying Q, Fan DN, Huang S,
Ding J, Yao J, Yan M, Li J, Yao M, et al: MicroRNA-125b
suppressesed human liver cancer cell proliferation and metastasis
by directly targeting oncogene LIN28B2. Hepatology. 52:1731–1740.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu LH, Li H, Li JP, Zhong H, Zhang HC,
Chen J and Xiao T: miR-125b suppresses the proliferation and
migration of osteosarcoma cells through down-regulation of STAT3.
Biochem Biophys Res Commun. 416:31–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu D, Ding J, Wang L, Pan H, Zhou Z, Zhou
J and Qu P: microRNA-125b inhibits cell migration and invasion by
targeting matrix metallopeptidase 13 in bladder cancer. Oncol Lett.
5:829–834. 2013.PubMed/NCBI
|
|
23
|
Henson BJ, Bhattacharjee S, O'Dee DM,
Feingold E and Gollin SM: Decreased expression of miR-125b and
miR-100 in oral cancer cells contributes to malignancy. Genes
Chromosomes Cancer. 48:569–582. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shang C, Lu YM and Meng LR: MicroRNA-125b
down-regulation mediates endometrial cancer invasion by targeting
ERBB2. Med Sci Monit. 18:BR149–BR155. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amir S, Ma AH, Shi XB, Xue L, Kung HJ and
White RW Devere: Oncomir miR-125b suppresses p14(ARF) to modulate
p53-dependent and p53-independent apoptosis in prostate cancer.
PLoS One. 8:e610642013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu N, Lin X, Zhao X, Zheng L, Xiao L, Liu
J, Ge L and Cao S: MiR-125b acts as an oncogene in glioblastoma
cells and inhibits cell apoptosis through p53 and
p38MAPK-independent pathways. Br J Cancer. 109:2853–2863. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang H, Luo XQ, Feng DD, Zhang XJ, Wu J,
Zheng YS, Chen X, Xu L and Chen YQ: Upregulation of microRNA-125b
contributes to leukemogenesis and increases drug resistance in
pediatric acute promyelocytic leukemia. Mol Cancer. 10:1082011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han Y, Liu Y, Zhang H, Wang T, Diao R,
Jiang Z, Gui Y and Cai Z: Hsa-miR-125b suppresses bladder cancer
development by down-regulating oncogene SIRT7 and oncogenic long
non-coding RNA MALAT1. FEBS Lett. 587:3875–3882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang JX, Gao S, Pan YZ, Yu C and Sun CY:
Overexpression of microRNA-125b sensitizes human hepatocellular
carcinoma cells to 5-fluorouracil through inhibition of glycolysis
by targeting hexokinase II. Mol Med Rep. 10:995–1002.
2014.PubMed/NCBI
|
|
30
|
Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ
and White RW: miR-125b promotes growth of prostate cancer xenograft
tumor through targeting pro-apoptotic genes. Prostate. 71:538–549.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hennighausen L and Robinson GW:
Interpretation of cytokine signaling through the transcription
factors STAT5A and STAT5B. Genes Dev. 22:711–721. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lütticken C, Wegenka UM, Yuan J, Buschmann
J, Schindler C, Ziemiecki A, Harpur AG, Wilks AF, Yasukawa K, Taga
T, et al: Association of transcription factor APRF and protein
kinase Jak1 with the interleukin-6 signal transducer gp130.
Science. 263:89–92. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dai L, Liu T, Zhou X, Wei Q, Li Y, Cui C
and Li M: Expression and significance of phosphated signal
transducer and activator of transcription 3 and p53 protein in
laryngeal squamous cell carcinoma. Lin Chung Er Bi Yan Hou Tou Jing
Wai Ke Za Zhi. 27:991–994. 2013.(In Chinese). PubMed/NCBI
|
|
34
|
Zhao H, Wamg Y and He X: Expression of
p-STAT3 in laryngeal squamous carcinoma and its correlation with
PTEN. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 27:981–985.
2013.(In Chinese). PubMed/NCBI
|
|
35
|
Wang L, Duan X, Tang X, Shao Y, Zhao R,
Qian X and Gao X: Clinical significance of Stat3 and Cyclin D1
expression in laryngeal squamous cell carcinoma. Lin Chung Er Bi
Yan Hou Tou Jing Wai Ke Za Zhi. 25:966–969. 2011.(In Chinese).
PubMed/NCBI
|
|
36
|
Zhong Z, Wen Z and Darnell JE Jr: Stat3: A
STAT family member activated by tyrosine phosphorylation in
response to epidermal growth factor and interleukin-6. Science.
264:95–98. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bromberg J and Darnell JE Jr: The role of
STATs in transcriptional control and their impact on cellular
function. Oncogene. 19:2468–2473. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kamran MZ, Patil P and Gude RP: Role of
STAT3 in cancer metastasis and translational advances. Biomed Res
Int. 2013:4218212013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xiong A, Yang Z, Shen Y, Zhou J and Shen
Q: Transcription factor STAT3 as a novel molecular target for
cancer prevention. Cancers (Basel). 6:926–957. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Siveen KS, Sikka S, Surana R, Dai X, Zhang
J, Kumar AP, Tan BK, Sethi G and Bishayee A: Targeting the STAT3
signaling pathway in cancer: Role of synthetic and natural
inhibitors. Biochim Biophys Acta. 1845:136–154. 2014.PubMed/NCBI
|
|
41
|
Zhang JF, He ML, Fu WM, Wang H, Chen LZ,
Zhu X, Chen Y, Xie D, Lai P, Chen G, et al: Primate-specific
microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by
disrupting signal transducer and activator of transcription 3
signaling. Hepatology. 54:2137–2148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lu Y, Yue X, Cui Y, Zhang J and Wang K:
MicroRNA-124 suppresses growth of human hepatocellular carcinoma by
targeting STAT3. Biochem Biophys Res Commun. 441:873–879. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhao G, Zhang JG, Shi Y, Qin Q, Liu Y,
Wang B, Tian K, Deng SC, Li X, Zhu S, et al: MiR-130b is a
prognostic marker and inhibits cell proliferation and invasion in
pancreatic cancer through targeting STAT3. PLoS One. 8:e738032013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang X, Tang J, Zhi X, Xie K, Wang W, Li
Z, Zhu Y, Yang L, Xu H and Xu Z: miR-874 functions as a tumor
suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway
in gastric cancer. Oncotarget. 6:1605–1617. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Miao L, Liu K, Xie M, Xing Y and Xi T:
miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis
by blocking JAK2-STAT3 signaling. Cancer Immunol Immunother.
63:699–711. 2014. View Article : Google Scholar : PubMed/NCBI
|
